First Time Loading...

BioDelivery Sciences International Inc
NASDAQ:BDSI

Watchlist Manager
BioDelivery Sciences International Inc Logo
BioDelivery Sciences International Inc
NASDAQ:BDSI
Watchlist
Price: 5.59 USD -0.09%
Updated: May 8, 2024

BioDelivery Sciences International Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioDelivery Sciences International Inc
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
BioDelivery Sciences International Inc
NASDAQ:BDSI
Revenue
$166.7m
CAGR 3-Years
44%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Revenue
$85.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$45.5B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$55.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Revenue
$61.4B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Revenue
$35.9B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
5%

BioDelivery Sciences International Inc
Revenue Breakdown

Breakdown by Geography
BioDelivery Sciences International Inc

Not Available

Breakdown by Segments
BioDelivery Sciences International Inc

Total Revenue: 166.7m USD
100%
Product Sales, Net: 164.6m USD
98.7%
Belbuca: 148.2m USD
88.9%
Symproic: 16.4m USD
9.8%
Product Royalty Revenues: 2.1m USD
1.3%
Show More
Show Less

See Also

What is BioDelivery Sciences International Inc's Revenue?
Revenue
166.7m USD

Based on the financial report for Dec 31, 2021, BioDelivery Sciences International Inc's Revenue amounts to 166.7m USD.

What is BioDelivery Sciences International Inc's Revenue growth rate?
Revenue CAGR 5Y
61%

Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for BioDelivery Sciences International Inc have been 44% over the past three years , 61% over the past five years .